Cooper Vascular and Endovascular Surgery is involved in a wide variety of clinical trials related to your vascular health. Being a participant in a study may allow the use of advanced devices that are pending FDA approval and which are not available to patients outside of the study. If you would like more information about our clinical trials or think that you might qualify to participate please make an appointment with Cooper Vascular Surgery to discuss your options. Our physicians will be able to determine your eligibility for a particular clinical trial based on a physical examination and a discussion with you.
Open Vascular and Endovascular Clinical Trials
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta – Joseph Lombardi, MD
This study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta. Includes Aortic Dissections, Trauma and Aneurysms.
National Clinical Trial Identified Number: NCT02777528
Prospective, multicenter, non-randomized study with consecutive, eligible subject enrollment at each site, for the evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms – Joseph Lombardi, MD
This study is to determine the safety and effectiveness of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms.
National Clinical Trial Identified Number: NCT04252573
Humacyte Human Acellular Vessel (HAV) in Patients with Vascular Trauma – Philip Batista, MD
This study evaluates the use of the Human Acellular Vessel (HAV) in adults with vascular trauma below the neck who are undergoing vascular reconstructive surgery.
National Clinical Trial Identified Number: NCT03005418